Fundamental evaluation of the CLEIA (chemiluminescent enzyme immunoassay) for measurement of C-peptide, and its clinical usefulness

Journal of the Japan Diabetes Society

Volumn 51, Issue 7, 2008, Pages 639-644

  Horie, M ^a   Ueda, K ^a   Shibasaki, S ^a   Terasaki, J ^a   Imagawa, A ^a   Hanafusa, T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 51149089480     PISSN: 0021437X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Japanese source
2. Japanese source
3. Japanese source
4. Japanese source
5. Japanese source
6. Japanese source
7. Japanese source
8. Japanese source
9. Reeves WG, Douglas CA (1982) C-peptide antibodies induced by bovine insulin therapy. Clin Exp Immunol 50 : 171-177
10. Rodriguez CD, Stöckl D, Kaufman JM, Fiers T, Thienpont LM (2006) Feasibility of standardization of serum C-Peptide immunoassays with isotope-dilution liquid chromatography-tandem mass spectrometry. Clin Chem 52 : 1193-1196
11. Rogatsky E, Baient B, Goswami G, Tomuta V, Jayatillake H, Cruikshank G, VeIe L, Stein DT (2006) Sensitive quantitative analysis of C-Peptide in human plasma by 2-dimensional liquid chromatography-mass spectrometry isotope-dilution assay. Clin Chem 52 : 872-879
12. Japanese source
13. Japanese source
14. Paty BW, Senior P, Alakey JR, Shapiro AM, Ryan EA (2006) Assessment of glycemic control after islet transplantation using the continuous glucose monitor in insulin-independent versus insulin-requiring type 1 diabetes subjects. Diabetes Technol Ther 8 : 165-173